首页> 外文期刊>Archives of pediatrics & adolescent medicine >Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.
【24h】

Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.

机译:遵守建议和机会接种疫苗的年龄在11到12年:评估2009个国家免疫survey-teen。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To determine vaccination coverage at selected ages and by birth cohort and to assess whether all indicated vaccines were administered during vaccination visits. DESIGN: Population-based cross-sectional study. SETTING: National Immunization Survey-Teen 2009 telephone interview. PARTICIPANTS: United States adolescents aged 13 to 17 years with provider-reported vaccination histories (N = 20 066). MAIN OUTCOME MEASURES: Among all adolescents and by birth cohort: coverage estimates for 3 childhood vaccines (measles-containing, hepatitis B, and varicella) and 3 adolescent vaccines (tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, meningococcal-containing, and human papillomavirus for girls) at selected ages. RESULTS: By age 11 years, most adolescents had obtained the childhood vaccines. Receipt of a tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis vaccine at ages 11 to 12 years increased significantly from the 1991 to 1996 birth cohort (33.8% vs 68.2%, P < .001); receipt of meningococcal-containing vaccine at ages 11 to 12 years increased significantly from the 1993 to 1996 birth cohort (8.4% vs 50.0%, P < .001). Among girls, receipt of human papillomavirus vaccine at ages 11 to 12 years increased significantly from the 1994 to 1996 birth cohort (11.1% vs 30.5%, P < .001). Overall, 54.9% of adolescents received at least 1 vaccination visit at ages 11 to 12 years. Among adolescents who made a vaccination visit at ages 11 to 12 years and were eligible for vaccination, 19.5% did not receive tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, 60.9% did not receive meningococcal-containing, and 62.4% did not receive human papillomavirus vaccines. CONCLUSIONS: Receipt of vaccines at the recommended ages of 11 to 12 years appears to be increasing; however, providers often do not administer all indicated vaccines during a vaccination visit.
机译:目的:确定疫苗接种覆盖率选择年龄和出生队列和评估是否所有表示疫苗接种在疫苗接种。以人群为基础的横断面研究。国家免疫Survey-Teen 2009电话面试。13至17岁的青少年provider-reported疫苗接种记录(N = 20066)。青少年和出生队列:覆盖估计3儿童疫苗(measles-containing乙型肝炎和水痘)和3 (tetanus-diphtheria青少年疫苗和/或tetanus-diphtheria-acellular百日咳、meningococcal-containing和人类在选定的年龄女孩乳头瘤病毒)。结果:11岁,大多数青少年获得了儿童疫苗。tetanus-diphtheria和/或tetanus-diphtheria-acellular百日咳疫苗年龄在11到12年显著增加1991年到1996年的出生队列(33.8%比68.2%,P<措施);疫苗的年龄在11到12年增加从1993年到1996年出生队列显著(8.4%比50.0%,P <措施)。人类乳头状瘤病毒疫苗在11到12岁从1994年到年显著增加1996出生队列(11.1%比30.5%,P <措施)。总的来说,54.9%的青少年接受了至少1疫苗接种访问在11到12岁。在年龄的青少年接种访问11到12年,合格的疫苗接种,没有收到tetanus-diphtheria和/或19.5%tetanus-diphtheria-acellular百日咳,60.9%没有收到meningococcal-containing, 62.4%没有收到人类乳头状瘤病毒疫苗。结论:收据的疫苗建议似乎是年龄在11到12年增加;管理所有疫苗期间表示疫苗接种的访问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号